Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jun;95(3):653-67.
doi: 10.1016/j.suc.2015.02.016.

Endoscopic treatment of gastroesophageal reflux disease

Kristin Hummel  1 , William Richards  2
Affiliations
Review

Endoscopic treatment of gastroesophageal reflux disease

Kristin Hummel et al. Surg Clin North Am. 2015 Jun.

Abstract

Multiple new endoluminal devices and therapies have been devised to create a more effective antireflux barrier in patients with gastroesophageal reflux disease (GERD). Most of these therapies have been abandoned, because they were ineffective and/or had significant adverse effects. However, there are currently two therapies (Stretta, EsophyX) that have US Food and Drug Administration approval and continue to be used in select patients with GERD. The clinical management of GERD, disease complications, endoluminal techniques, evidence for efficacy, and controversies concerning endoluminal therapy for GERD are reviewed and discussed.

Keywords: Endoluminal devices; EsophyX; Gastroesophageal reflux disease; Stretta.

PubMed Disclaimer